21225 ⎘
Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
COMPOSITIONS AND METHODS CONCERNING IMMUNE TOLERANCE
#2COMPOSITIONS FOR DELIVERY OF PLASMODIUM CSP ANTIGENS AND RELATED METHODS
#3COVALENT POLYMER-ANTIGEN CONJUGATED PARTICLES
#4POLYMERIC NANOVACCINES AND USES THEREOF
#5NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
#6CONDITIONING FOR IN VIVO IMMUNE CELL ENGINEERING
#7VACCINE COMPOSITIONS AND USES THEREOF
#8CORONAVIRUS VACCINE
#9COMBINATION CONTAINING AN MRNA VACCINE OR AN MRNA ENCODED THERAPEUTIC PROTEIN AND AN IMMUNE MODULATING MRNA FOR IMPROVED OR REDUCED IMMUNOGENICITY TO INCREASE EFFICACY
#10BIODEGRADABLE POLYMERIC PARTICLES FOR DELIVERY OF POSITIVELY CHARGED THERAPEUTIC AGENTS
#11METHODS FOR TREATING OR PREVENTING RESPIRATORY DISEASES IN CATTLE USING POLYMERS AND POLYPLEXES FOR mRNA DELIVERY AND mRNA THERAPY
#12MEMBRANE VESICLES COMPRISING MULTIPLE INFLUENZA ANTIGENS FOR VACCINES
#13Immunogenic Compositions of PEGylated Polysaccharide Compounds
#14VIRUS-LIKE PARTICLES FOR PREVENTING THE SPREADING AND LOWERING THE INFECTION RATE OF VIRUSES
#15PAYLOAD DELIVERY SYSTEM
#16SELF-REPLICATING RNA VACCINES AND METHODS OF USE
#17GLYCOTARGETING THERAPEUTICS
#18INJECTABLE HYDROGELS FOR CONTROLLED RELEASE OF IMMUNOMODULATORY COMPOUNDS
#19METHODS OF MANUFACTURING PEPTIDE-BASED VACCINES
#20Tolerizing Immune Modifying Nanoparticles for Overcoming the Immunogenicity of Therapeutic Vectors and Proteins
#21mRNA-based HIV Vaccine For Acute and Latent Infections
#22POLYNUCLEOTIDE VACCINE FORMULATIONS AND METHODS OF USING THE SAME
#23IMMUNOGENICITY OF PLASMODIUM VIVAX CIRCUMSPOROZOITE PROTEIN NANOPARTICLE VACCINES
#24NOVEL LIPIDS BASED ON OLIGO-y-GLUTAMIC ACID DERIVATIVES AND LIPID NANOPARTICLES CONTAINING THE SAME, AND USES THEREOF
#25COMPOSITE BIOACTIVE COMPOSITIONS AND APPLICATIONS THEREOF
#26GLYCOTARGETING THERAPEUTICS
#27SELF-ASSEMBLING NANOPARTICLES
#28INJECTABLE PROLONGED-RELEASE HYDROGEL FORMULATIONS OF TOLL-LIKE RECEPTOR AGONISTS FOR INTRATUMORAL INJECTION TO INCREASE IMMUNOTHERAPY RESPONSE
#29METHODS OF TARGETED DELIVERY TO A HOST USING A CARRIER
#30CORONAVIRUS VACCINE
#31COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#32CARRIER FOR LOWERING THE INFECTION RATE OF BACTERIA
#33POLYMER ADJUVANT
#34HENIPAVIRUS VACCINE
#35MODIFIED BIOTIN-BINDING PROTEIN, FUSION PROTEINS THEREOF AND APPLICATIONS
#36Methods of fabricating carriers for targeted delivery to a host
#37FORMULATIONS FOR SMALL INTESTINAL DELIVERY
#38IMPROVED CIRCULAR RNA FOR EXPRESSING THERAPEUTIC PROTEINS
#39NASAL VACCINE-SPRAYING FORMULATION FOR SIMULTANEOUSLY TARGETING NASAL MUCOSA AND NASOPHARYNX
#40Peptide Conjugated Particles
#41MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION, AND METHODS AND USES THEREOF
#42MICROPOROUS ANNEALED PARTICLE GEL SYSTEM
#43NOVEL LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS COMPRISING PHOSPHATIDYLSERINE
#44MUCOADHESIVE-PLGA NANOPARTICLES
#45VACCINE FOR SARS-COV-2
#46POLY(ETHYLENE GLYCOL) HAVING C1 TO C3-ALKYLOXYMETHYL SIDE CHAINS, BIOCONJUGATES THEREOF, PROCESS FOR ITS PREPARATION AND ITS USE
#47COMPOSITION FOR IMMUNE TREATMENT OF ALLERGIC DISEASES COMPRISING HOUSE DUST MITE ANTIGENS AND HYALURONIC ACID HYDROGELS AS ACTIVE INGREDIENTS
#48SUBUNIT VACCINES WITH DINUCLEOTIDE-LOADED HYDROGEL ADJUVANT
#49NANOPARTICLES COMPRISING PEPTIDES INCLUDING AN N-TERMINAL LINKER
#50Coronavirus vaccine
#51Self-Assembling Nanoparticles
#52COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE
#53POLYNUCLEOTIDES CAPABLE OF ENHANCED PROTEIN EXPRESSION AND USES THEREOF
#54TREATMENT OF PEANUT ALLERGY WITH TOLERIZING NANOPARTICLES
#55NANOVACCINES FOR TREATMENT OF VIRAL DISEASES
#56MICROMOLDED OR 3-D PRINTED PULSATILE RELEASE VACCINE FORMULATIONS
#57IMMUNOGENIC COMPOSITIONS
#58PEPTIDE VACCINE FORMULATIONS AND USE THEREOF FOR INDUCING AN IMMUNE RESPONSE
#59MULTIPLE SCLEROSIS ASSOCIATED AUTOANTIGENS, AND USE THEREOF IN THERAPY AND DIAGNOSIS
#60Carrier for targeted delivery to a host
#61MONOVALENT AND MULTIVALENT VACCINES FOR PREVENTION AND TREATMENT OF DISEASE
#62PATHOGEN VACCINES AND METHODS OF PRODUCING AND USING THE SAME
#63PEPTIDE CONJUGATED PARTICLES
#64NANOPARTICLE COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
#65REACTIVE MICROPARTICLES AND THEIR USE TO PREPARE FUNCTIONAL HYDROGEL PARTICLES
#66Fluorocarbon-Linked Peptide Formulation
#67CARBOHYDRATE STRUCTURES AND USES THEREOF
#68BIOCOMPATIBLE NANOCOMPOSITE HYDROGEL IMMUNOTHERAPY VACCINES AND METHODS OF USE THEREOF
#69Modified biotin-binding protein, fusion proteins thereof and applications
#70AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#71Nanoparticles comprising peptides including an n-terminal linker
#72Coronavirus vaccine
#73COVALENT POLYMER-ANTIGEN CONJUGATED PARTICLES
#74NUCLEIC ACID NANOSTRUCTURE PLATFORM FOR PROGRAMMING IMMUNE STIMULATION
#75Coronavirus vaccine
#76BONE-PROMOTING THERMORESPONSIVE MACROMOLECULES
#77Coronavirus vaccine
#78IMMUNOGENIC CONSTRUCTS, COMPOSITIONS, AND METHODS FOR INDUCING IMMUNE RESPONSE
#79ANTI-INFECTION AND ANTI-TUMOR MUCOSAL IMMUNE PREPARATION
#80Henipavirus vaccine
#81TUMOR VACCINE, PREPARATION METHOD THEREFOR AND USE THEREOF
#82Virus-like particles for preventing the spreading and lowering the infection rate of viruses
#83GLYCOTARGETING THERAPEUTICS
#84COMPOUNDS FOR THE INDUCTION OF ANTIGEN-SPECIFIC IMMUNE TOLERANCE
#85Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response
#86AN ANAPLASTIC LYMPHOMA KINASE (ALK) CANCER VACCINE AND METHODS OF USE
#87POLYMER NANOPARTICLE COMPOSITION FOR INDUCING IMMUNITY AND PREPARATION METHOD THEREFOR
#88Coronavirus vaccine
#89POLYMERIC NANOPARTICLES THAT TARGET LIVER SINUSOIDAL ENDOTHELIAL CELLS TO INDUCE ANTIGEN-SPECIFIC IMMUNE TOLERANCE
#90Microporous annealed particle gel system
#91BRUSH POLYMERS FOR THERAPEUTIC APPLICATIONS
#92A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMES
#93Virus-like particles for preventing the spreading and lowering the infection rate of viruses
#94NANOPARTICLES FOR USE IN REDIRECTION AGAINST THE TUMOUR OF A NON-TUMOUR SPECIFIC IMMUNE RESPONSE, BASED ON A PRE-EXISTING IMMUNITY
#95Coronavirus vaccine
#96MOMP telonanoparticles, and related compositions, methods and systems
#97COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE
#98Immunogen for Preventing or Treating Familial Frontotemporal Dementia (FTD) and/or Amyotrophic Lateral Sclerosis (ALS)
#99Coronavirus vaccine
#100A Composition for the Delivery of Biologically Active Agents and Uses Thereof
#101Nucleic acid vaccination using neo-epitope encoding constructs
#102Peptide vaccine formulations and use thereof for inducing an immune response
#103Compositions Comprising Apoptotic Signaling and Methods for Induction of Antigen-Specific Tolerance
#104METHOD FOR ELICITING AN IMMUNE RESPONSE TO AN IMMUNOGEN
#105PHAGOCYTISABLE PARTICLE FOR USE IN THE TREATMENT OR PROPHYLAXIS OF CANCER
#106IMMUNOGENIC CONSTRUCTS, COMPOSITIONS, AND METHODS FOR INDUCING IMMUNE RESPONSE
#107POLYMERIC NANOVACCINES AND USES THEREOF
#108Biodegradable cationic polycarbonates as adjuvants for vaccines
#109Poly(diaminosulfide) particle-based vaccine
#110Cytosolic delivery of peptides using protein transduction domain mimics
#111Immunotherapy against several tumors including neuronal and brain tumors
#112METHODS FOR IDENTIFYING CHIMERIC ANTIGEN RECEPTOR-TARGETING LIGANDS AND USES THEREOF
#113INJECTABLE HYDROGELS FOR CONTROLLED RELEASE OF IMMUNOMODULATORY COMPOUNDS
#114Multiple antigen presenting immunogenic composition, and methods and uses thereof
#115Albumin binding peptide conjugates and methods thereof
#116MICROCAPSULE-BASED VACCINE
#117METHOD OF LONG-TERM PRESERVATION OF CHEMICAL AND BIOLOGICAL SPECIES USING SUGAR GLASSES
#118Immunotherapy against several tumors including neuronal and brain tumors
#119Immunotherapy against several tumors including neuronal and brain tumors
#120COMPOSITIONS AND METHODS CONCERNING IMMUNE TOLERANCE
#121Immunotherapy against several tumors including neuronal and brain tumors
#122Micromolded or 3-D printed pulsatile release vaccine formulations
#123Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response
#124Broad spectrum influenza virus vaccine
#125Pathogen vaccines and methods of producing and using the same
#126COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#127IMPROVED METHODS OF MANUFACTURING PEPTIDE-BASED VACCINES
#128MULTIPLE SCLEROSIS ASSOCIATED AUTOANTIGENS, AND USE THEREOF IN THERAPY AND DIAGNOSIS
#129Immunostimulatory compositions
#130Fluorocarbon-linked peptide formulation
#131EXPRESSION VECTOR DELIVERY SYSTEM AND USE THEREOF FOR INDUCING AN IMMUNE RESPONSE
#132POLYMER ADJUVANT
#133Modified biotin-binding protein, fusion proteins thereof and applications
#134NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE
#135EXTRACELLULAR TARGETED DRUG CONJUGATES
#136Compositions and methods for immunotherapy
#137Peptide conjugated particles
#138Microporous annealed particle gels and methods of use
#139Nanoparticle compositions and methods for immunotherapy
#140Nanoparticles for treatment of allergy
#141Nucleic acid nanostructure platform for antigen presentation and vaccine formulations formed therefrom
#142COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE
#143Methods and compositions for inducing protective immunity
#144Hydrogel delivery of sting immunotherapy for treatment cancer
#145Glycotargeting therapeutics
#146Tumor vaccine and uses thereof
#147Glycotargeting therapeutics
#148Compositions and methods for inducing immune tolerance
#149Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
#150PEPTIDE-BASED VACCINES, METHODS OF MANUFACTURING, AND USES THEREOF FOR INDUCING AN IMMUNE RESPONSE
#151MOMP telonanoparticles, and related compositions, methods and systems
#152COMPOSITIONS AND METHODS FOR DELIVERY OF POLYMER/BIOMACROMOLECULE CONJUGATES
#153Influenza nanovaccine
#154Compositions Comprising Apoptotic Signaling and Methods for Induction of Antigen-Specific Tolerance
#155Henipavirus vaccine
#156Nicotine nanovaccines and uses thereof
#157Carbohydrate structures and uses thereof
#158Bone-promoting thermoresponsive macromolecules
#159Micromolded or 3-D printed pulsatile release vaccine formulations
#160Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
#161Covalent polymer-antigen conjugated particles
#162Peptide conjugated particles for the treatment of inflammation
#163Hydrogel for engineered immune response to D-chirality peptides
#164Scaffolds for cell transplantation
#165Injectable composition for delivery of a biologically active agent
#166Modified biotin-binding protein, fusion proteins thereof and applications
#167MODULAR NANODEVICES FOR SMART ADAPTABLE VACCINES
#168Method of long-term preservation of chemical and biological species using sugar glasses
#169Peptide vaccine formulations and use thereof for inducing an immune response
#170Methods of treating cancer cells expressing tumor-associated integrins
#171Albumin binding peptide conjugates and methods thereof
#172Nanoparticle compositions and methods for immunotherapy
#173NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
#174Anti-infection and anti-tumor mucosal immune preparation
#175Immunostimulatory compositions
#176Antigen-specific, tolerance-inducing microparticles and uses thereof
#177Method of eliciting an anti-tumor immune response with controlled delivery of TLR agonists in porous polymerlc devices
#178Polymer conjugate vaccines
#179Expression vector delivery system and use thereof for inducing an immune response
#180IMMUNOMODULATORY AGENT-POLYMERIC COMPOUNDS
#181COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
#182Method for eliciting an immune response to an immunogen
#183Carrier for use in delivering drug, conjugate, composition comprising same, and method for administrating same
#184Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
#185PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC REACTIONS
#186HOLLOW SILICA NANOSPHERES AND METHODS OF MAKING SAME
#187Production method for poly(amino acid)
#188DOSE SELECTION OF ADJUVANTED SYNTHETIC NANOCARRIERS
#189COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#190POLYMER ADJUVANT
#191Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
#192Pathogen vaccines and methods of producing and using the same
#193Carbon nanotube compositions and methods of use thereof
#194Polymer-protein core-shell particles as effective vaccine delivery vehicles and treatments methods using the same
#195Conjugates of an anti-TNF-alpha antibody
#196Vaccination with immuno-isolated cells producing an immunomodulator
#197Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
#198Crosslinked vaccination composition
#199Biodegradable nanocomplex
#200Bifunctional conjugate compositions and associated methods
#201Immunotherapy against several tumors including neuronal and brain tumors
#202Immunotherapy against several tumors including neuronal and brain tumors
#203Immunotherapy against several tumors including neuronal and brain tumors
#204Immunotherapy against several tumors including neuronal and brain tumors
#205Immunotherapy against several tumors including neuronal and brain tumors
#206Immunotherapy against several tumors including neuronal and brain tumors
#207Immunotherapy against several tumors including neuronal and brain tumors
#208Hollow silica nanospheres and methods of making same
#209Extracellular targeted drug conjugates
#210CARBOHYDRATE-MODIFIED PARTICLES AND PARTICULATE FORMULATIONS FOR MODULATING AN IMMUNE RESPONSE
#211Peptide particle formulation
#212Controlled delivery of TLR3 agonists in structural polymeric devices
#213Carrier for use in delivering drug, conjugate, composition comprising same, and method for administrating same
#214Scaffolds for cell transplantation
#215Scaffolds for cell transplantation
#216COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#217Glycotargeting therapeutics
#218Particles with multiple functionalized surface domains
#219Continuous Cell Programming Devices
#220Continuous cell programming devices
#221Production method for poly(amino acid)
#222Antigenic compositions and methods
#223COMPOSITIONS AND METHODS FOR INDUCTION OF ANTIGEN-SPECIFIC TOLERANCE
#224Immunogenic composition in emulsion form comprising two dispersed phases, one comprising an antigen and the other comprising an immunostimulating agent
#225COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
#226Modified biotin-binding protein, fusion proteins thereof and applications
#227Recombinant neuraminidase and uses thereof
#228Fluorocarbon-linked peptide formulation
#229COMPOSITIONS AND METHODS FOR IMMUNE TOLERANCE INDUCTION TO FACTOR VIII REPLACEMENT THERAPIES IN SUBJECTS WITH HEMOPHILIA A
#230Immunogenic composition
#231Immunogenic composition in emulsion form
#232Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
#233TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE CYTOTOXIC T LYMPHOCYTE RESPONSES
#234Glycotargeting therapeutics
#235METHODS AND COMPOSITIONS FOR TREATMENT WITH SYNTHETIC NANOCARRIERS AND IMMUNE CHECKPOINT INHIBITORS
#236Scaffolds for cell transplantation
#237TOLEROGENIC SYNTHETIC NANOCARRIERS FOR T-CELL-MEDIATED AUTOIMMUNE DISEASE
#238Dose selection of adjuvanted synthetic nanocarriers
#239Immunomodulatory agent-polymeric compounds
#240Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
#241Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
#242THERAPEUTIC AND VACCINE POLYELECTROLYTE NANOPARTICLE COMPOSITIONS
#243Method for eliciting an immune response to an immunogen
#244Composition of viral vectors in lecithin liposomes, preparation method and treatment methods
#245Induction of antigen-specific tolerance by peripheral phagocytosis
#246Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
#247Antibodies obtainable using supramolecular constructs
#248INFLUENZA VACCINES WITH REDUCED AMOUNT OF EMULSION ADJUVANT
#249Micromolded or 3-D printed pulsatile release vaccine formulations
#250Composition comprising a colloidal synthetic bioresorbable vector and a viral vector
#251Immunotherapy against several tumors including neuronal and brain tumors
#252Modular nanodevices for smart adaptable vaccines
#253Antigenic compositions and methods
#254MICROPARTICLES FOR USE IN IMMUNOGENIC COMPOSITIONS
#255Immunogenic complexes of polyanionic carbomers and Env polypeptides and methods of manufacture and use thereof
#256Combination adjuvant formulation
#257Vaccine composition capable of inducing memory antibody response from single point immunization
#258Immunomodulatory agent-polymeric compounds
#259Multiple antigen presenting immunogenic composition, and methods and uses thereof
#260Methods for polymering haptens into immunogens
#261Protein matrix vaccine compositions including polycations
#262Fluorocarbon-linked peptide formulation
#263Antigen-specific, tolerance-inducing microparticles and uses thereof
#264Antigenic compositions and methods
#265Hollow silica nanospheres and methods of making same
#266Carbon nanotube compositions and methods of use thereof
#267Controlled delivery of TLR agonists in structural polymeric devices
#268Bioresorbable nonlamellar microparticles and uses thereof
#269PHARMACEUTICAL COMPOSITION CAPABLE OF IMMUNO-REGULATION OR ENHANCEMENT OF IMMUNE RESPONSE
#270METHODS OF USING AGENTS THAT MODULATE CLAUDIN EXPRESSION
#271METHODS OF USING AGENTS THAT MODULATE CLAUDIN EXPRESSION
#272Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
#273Tolerogenic synthetic nanocarriers for allergy therapy
#274Tolerogenic synthetic nanocarriers
#275Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses
#276Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
#277Benzonaphthyridine-containing vaccines
#278HIV vaccine formulations
#279Polyethylene glycol-based dendrons
#280MUCOSAL BOOSTING FOLLOWING PARENTERAL PRIMING
#281Particles with multiple functionalized surface domains
#282Immunotherapy against several tumors including neuronal and brain tumors
#283Scaffolds for cell transplantation
#284Immunogenic compositions containing phospholipid
#285Continuous cell programming devices
#286Immunonanotherapeutics that provide IGG humoral response without T-cell antigen
#287Method for prophylaxis of influenza using vaccine for intranasal administration
#288COMPOSITIONS AND METHODS FOR INDUCTION OF ANTIGEN-SPECIFIC TOLERANCE
#289SYNTHETIC NANOCARRIER VACCINES COMPRISING PEPTIDES OBTAINED OR DERIVED FROM HUMAN INFLUENZA A VIRUS HEMAGGLUTININ
#290SYNTHETIC NANOCARRIER VACCINES COMPRISING PEPTIDES OBTAINED OR DERIVED FROM HUMAN INFLUENZA A VIRUS M2E
#291SYNTHETIC NANOCARRIER VACCINES COMPRISING PROTEINS OBTAINED OR DERIVED FROM HUMAN INFLUENZA A VIRUS HEMAGGLUTININ
#292Methods and compositions comprising supramolecular constructs
#293Dose selection of adjuvanted synthetic nanocarriers
#294Methods and systems for inducing immunologic tolerance to non-self antigens
#295Respiratory syncytial virus antigenic compositions and methods
#296Peptide particle formulation
#297SYNTHETIC NANOCARRIER COMBINATION VACCINES
#298MULTIVALENT SYNTHETIC NANOCARRIER VACCINES
#299NANOCARRIER COMPOSITIONS WITH UNCOUPLED ADJUVANT
#300MICROPARTICLES FOR USE IN IMMUNOGENIC COMPOSITIONS